Immuron Limited (ASX:IMC)’s share price was down 10% during mid-day trading on Wednesday . The stock traded as low as A$0.14 ($0.10) and last traded at A$0.14 ($0.10), approximately 571,942 shares were traded during trading. The stock had previously closed at A$0.15 ($0.11).
The business has a fifty day moving average of A$0.13. The stock has a market cap of $23.87 million and a PE ratio of -4.22.
About Immuron (ASX:IMC)
Immuron Limited, a biopharmaceutical company, focuses on the research and development of immunomodulatory polyclonal antibodies for the treatment and prevention of various diseases through its oral immunoglobulins platform in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments.
Receive News & Ratings for Immuron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immuron and related companies with MarketBeat.com's FREE daily email newsletter.